Vivos Therapeutics

$6.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-0.60%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell VVOS and other stocks, options, and ETFs commission-free!

About VVOS

Vivos Therapeutics, Inc. Common Stock, also called Vivos Therapeutics, is a medical technology company, which engages in development and commercialization of differentiated technology offering clinically effective non-surgical, non-invasive, non-pharmaceutical, and low-cost solutions. Its solutions are offered for patients with SDB, including mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Highlands Ranch, CO. The listed name for VVOS is Vivos Therapeutics, Inc. Common Stock.

CEO
R. Kirk Huntsman
Employees
—
Headquarters
Highlands Ranch, Colorado
Founded
2016
Market Cap
127.48M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
147.51K
High Today
$6.90
Low Today
$6.15
Open Price
$6.79
Volume
69.72K
52 Week High
$14.41
52 Week Low
$5.64

VVOS Earnings

Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
—

You May Also Like

CHAA=
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure